Echosens

👨⚕️ Congratulations to Dr. Jörn Schattenberg, Director of the Department of Internal Medicine II at the Saarland University Medical Center, and a 2024 Echosens Liver Health Super Shaper Award recipient! Dr. Schattenberg is recognized as a leader in hepatology and steatotic liver disease, with extensive research and a steadfast commitment to advancing liver health. His dedication to research and his contributions to medical societies have strengthened the field, while his mentorship of emerging hepatologists ensures a future generation equipped with the expertise to fight liver disease. Join us in celebrating Dr. Schattenberg’s invaluable role in improving liver health worldwide! #LiverHealthMatters https://lnkd.in/ef7r3vDK

👩⚕️ We’re honored to recognize Dr. Catherine Williamson, Professor of Women’s Health at Imperial College London, as a 2024 Echosens Liver Health Super Shaper Award recipient! Dr. Williamson has been a trailblazer in understanding liver disease in pregnancy, focusing on conditions like intrahepatic cholestasis and hyperemesis gravidarum. Her pioneering work in genetic screening and clinical trials is advancing care for mothers and children worldwide. Dr. Williamson’s ability to bridge obstetrics and hepatology has improved patient outcomes and expanded global knowledge in this critical area. Join us in celebrating her invaluable contributions to liver health! #LiverHealthMatters https://lnkd.in/ef7r3vDK

🌟 We are proud to remember and honor Dr. Stephen Harrison, an extraordinary figure in hepatology and recipient of the Echosens Liver Health Legacy Award. Known as one of the most prominent hepatologists of recent decades, Dr. Harrison played an instrumental role in pioneering clinical research and advancing treatments for liver disease. His contributions have helped shape the modern approach to liver health, and his passing earlier this year was a great loss to the medical community. Echosens is deeply grateful for Dr. Harrison’s leadership, vision, and commitment to advancing liver health worldwide. His contributions will remain an enduring force in our field. Join us in remembering and honoring his impactful legacy. https://lnkd.in/ef7r3vDK

📸 Take a look back at the reception that was held to celebrate the recipients of the inaugural Echosens Liver Health Super Shaper Award at AASLD: The Liver Meeting 2024. This special event honored three outstanding individuals for their truly exceptional contributions to liver health. We'll share more about each of these remarkable physicians and their inspiring work next week, so stay tuned! ⌛ 👉 https://lnkd.in/ef7r3vDK

📺 Save the date for our upcoming #webinar on the Collaborative Approaches of Hepatology and Diabetology Specialists in the Identification and Management of #MASLD patients in Asia- Pacific. Prof. Wai-Kay Seto, Gastroenterologist and Hepatologist, and Prof. Paul Lee, Endocrinologist, will be our speakers to share how collaboration between disciplines is essential to identify and manage the Type 2 Diabetes Patient, a high-risk patient population for MASLD, at an early stage. Tailored to everyday clinical practice, this session would provide useful information on interdisciplinary patient care pathways, clinical guidelines and diagnostic thresholds, as well as sharing clinical cases in the management of MASLD in patients with Type 2 Diabetes. 📍 Secure your spot now and join us : https://lnkd.in/ebci8bhU #LiverHealthMatters

📢 We’re thrilled to share the winners of the inaugural Echosens Liver Health Super Shaper Award, first revealed yesterday at AASLD: The Liver Meeting 2024! These exceptional physicians have made transformative contributions to liver health and improved lives worldwide. This award honors their dedication, innovation, and impact on the field:   🌟 Dr. Stephen Harrison: Remembered with the Echosens Liver Health Legacy Award for his pioneering contributions.    👩⚕️ Dr. Catherine Williamson: Advancing liver disease research in pregnancy.   👨⚕️ Dr. Jörn Schattenberg: A leader in hepatology and mentor to future specialists.   Each of these honorees has left a lasting mark on liver health. Join us in celebrating their remarkable achievements and commitment to this critical field.  #LiverHealthMatters  https://lnkd.in/ef7r3vDK 👇

🎉Join us tonight to celebrate the first two winners of the Liver Health Super Shaper Award, which recognizes healthcare professionals for their outstanding contribution to improving the lives of patients with chronic liver disease! Chosen by an international panel, the two winners will be rewarded with the opportunity to donate $10,000 to a charity of their choice. 📍Meet at Marriott Marquis, from 4:30-6:30pm, in the Pacific Ballroom Section 14 - San Diego

#AASLD2024 Congress is currently taking place at in San Diego, CA! We're glad to participate in this year's event and meet you at booth #1523. We look forward to sharing the latest product innovations and presenting you Next Generation FibroScan® through our booth scanning demos! #FibroScan #LiverHealthMatters

Did you know that Type 2 #Diabetes (T2D) is a risk factor to metabolic dysfunction-associated steatotic liver disease #MASLD, the most prevalent chronic liver condition worldwide? Indeed the global prevalence of MASLD among T2D patients is 55.5%, and 17% of the patients with MASLD and T2D have advanced liver fibrosis. On World Diabetes Day this year, let’s shine a light on the link between MASLD & T2D and empower individuals with the knowledge they need. By understanding the risks and making informed lifestyle changes, we can help pave the way for healthier lives. Learn more on diabetes 👉 https://lnkd.in/dcJMsBe Learn more on liver health 👉 https://lnkd.in/dFkYp83 #WorldDiabetesDay

A new #HDV study performed in 230 patients confirms #FibroScan's high diagnostic value for detecting advanced fibrosis and cirrhosis in patients with chronic hepatitis delta. ✴️ FibroScan® demonstrated strong diagnostic performance with AUROC of 0.88 and 0.86 for advanced fibrosis and cirrhosis respectively, outperforming APRI and FIB-4. Based on the data, a cut-off value of >12kPa was identified for detecting #cirrhosis with excellent specificity and sensitivity, while values below 6kPa could be used to totally exclude significant #fibrosis. ➡️ These findings support the use of FibroScan® as a Non-Invasive Test for stratifying HDV patients and limiting the use of liver biopsy. Read the article here: https://lnkd.in/eENeNmju #LiverHealthMatters